Oral vs intravenous fluoropyrimidines
Grade ≥ 3 neutropenia/granulocytopenia · Patients treated with curative intent for colorectal cancer with neoadjuvant and/or adjuvant chemotherapy
Oral probably leads to lower grade ≥ 3 neutropenia/granulocytopenia compared with intravenous fluoropyrimidines (moderate certainty).
1 finding from 1 review
- Oral versus intravenous fluoropyrimidines for colorectal cancer 2017 · Cochrane Headline outcomes onlyOR 0.14 [0.11, 0.16]7 studies · 8087 participantsModerate